THZ2 T7296
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
THZ2, an analog of THZ1, is a potent and selective CDK7 inhibitor(IC50:13.9 nM),with the potential to treat Triple-negative breast cancer (TNBC).
CAS nr:
1604810-84-5
Purity:
98%
Molecular Weight:
566,05
SMILES:
CN(C)C\C=C\C(=O)Nc1cccc(c1)C(=O)Nc1cccc(Nc2ncc(Cl)c(n2)-c2c[nH]c3ccccc23)c1
Formula:
C31H28ClN7O2
Pathway:
Cell Cycle/Checkpoint
Target:
CDK
